Is a complete OCUL research report available?

No complete published report is available for Ocular Therapeutix, Inc. (OCUL) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Ocular Therapeutix, Inc. (OCUL)

NASDAQ: OCUL · USD

$8.62

+0.03 (+0.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-24 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first OCUL analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1.9B
Revenue (ttm)	52M
Net income (ttm)	-290.5M
EPS (ttm)	-$1.45
Shares out	219M
Volume	1,811,974
Beta	0.88
Price target	$27.1	+214.3%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 52M
Net income (ttm): -290.5M
EPS (ttm): -$1.45
Market cap: 1.9B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All OCUL indicators

Market & fundamental data

Available fields

207

Groups with data

Currency

USD

Showing 207 of 207 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001393434
Company name	Ocular Therapeutix, Inc.
Country	United States
Country code	US
Cusip	67576A100
Employees	325
Employees Change	51%
Employees Change Percent	18.61
Enterprise value	$1.3B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2014-07-25
Isin	US67576A1007
Last refreshed	2026-07-24
Market cap	$1.9B
Market cap category	Small-Cap
Price	$8.62
Price currency	USD
Rev Per Employee	160,116.92x
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.64
Sic	2834
Symbol	OCUL
Website	https://www.ocutx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-15.39%
EV Sales Forward	23.77x
EV/Sales	24.99x
FCF yield	-12.77%
P/B ratio	3.24x
P/S ratio	36.27x
PS Forward	34.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-575.42%
EBITDA Margin	-566.54%
Gross Profit	$-175.1M
Net Income	$-290.5M
Net Income Growth Years	0%
Pretax Margin	-558.24%
Profit Per Employee	$-893,840
ROA	-32.88
Roa5y	-25.86
ROCE	-43.72
ROE	-68.55
Roe5y	-80.17
ROIC	-37.31

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	5.25%
Cagr1y	-25.38%
Cagr3y	23.46%
Cagr5y	-6.59%
EPS Growth Years	0
Revenue Growth	-12.76x
Revenue Growth Q	0.81x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	0.23x
Revenue Growth5 Y	18.64x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.09
Assets	$732.5M
Cash	$666.7M
Current Assets	$706M
Current Liabilities	$47.7M
Debt	$79.5M
Debt Equity	$0.14
Equity	$581.6M
Interest Coverage	-25.75
Liabilities	$151M
Long Term Assets	$26.5M
Long Term Liabilities	$103.3M
Net Cash	$587.2M
Net Cash By Market Cap	$31.11
Net Cash Growth	114.75%
Net Debt Equity	$-1.01
Tangible Book Value	$581.6M
Tangible Book Value Per Share	$2.66
WACC	9.19

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	14.81
Inventory Turnover	64.83
Net Working Capital	$-5.2M
Quick ratio	14.49
Working Capital	$658.3M
Working Capital Turnover	$0.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-19.87%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	66.73%
1Y total return	-25.37%
200-day SMA	10.2
3Y total return	88.21%
50-day SMA	9.15
50-day SMA vs 200-day SMA	50under200
5Y total return	-28.88%
All Time High	44.19
All Time High Change	-80.49%
All Time High Date	2015-03-25
All Time Low	2
All Time Low Change	332.08%
All Time Low Date	2023-11-10
ATR	0.53
Beta	0.88
Beta1y	0.98
Beta2y	1.37
Ch YTD	-29
High	8.68
High52	16.44
High52 Date	2025-12-08
High52ch	-47.57%
Low	8.32
Low52	6.23
Low52 Date	2026-02-17
Low52ch	38.36%
Ma50ch	-5.78%
Premarket Change Percent	-0.99
Premarket Price	$8.5
Premarket Volume	5,591
Price vs 200-day SMA	-15.48%
RSI	39.16
RSI Monthly	48.27
RSI Weekly	45.23
Sharpe ratio	-0.14x
Sortino ratio	-0.13
Total Return	-19.87%
Tr YTD	-29
Tr1m	-13.54%
Tr1w	-5.95%
Tr3m	-10.77%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	11
Analyst Count Top	6
Analyst Price Target Top	$24.8
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.39
Earnings Revenue Estimate	13,095,960x
Earnings Revenue Estimate Growth	-2.7x
Operating Income	$-299.4M
Operating margin	-575.4
Price target	$27.09
Price Target Change	$214
Price Target Change Top	$188

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	184,373,041%
Float Percent	84.2%
Shares Insiders	1.18%
Shares Institutions	80.16%
Shares Out	218,960,358
Shares Qo Q	0.53%
Shares Yo Y	19.87%
Short Float	14.48%
Short Ratio	8.46
Short Shares	12.19

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-289.3M
Average Volume	2,410,657.45x
Bv Per Share	2.66
CAPEX	$-14.7M
Ch10y	66.73
Ch1m	-13.54
Ch1w	-5.95
Ch1y	-25.37
Ch3m	-10.77
Ch3y	88.21
Ch5y	-28.88
Ch6m	-22.48
Change	0.35%
Change From Open	1.41
Close	8.59
Days Gap	-1.05
Depreciation Amortization	4,625,000
Dollar Volume	15,619,215.9
Earnings Date	2026-08-06
Earnings Time	bmo
EBIT	$-299.4M
EBITDA	$-294.8M
EPS	$-1.45
F Score	2
FCF	$-240.9M
FCF EV Yield	-18.53x
FCF Per Share	$-1.1
Financing CF	557,832,000
Fiscal Year End	December
Founded	2,006
Investing CF	-14,609,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-05
Ma150	9.58
Ma150ch	-10.04%
Ma20	9.6
Ma20ch	-10.18%
Net CF	317,018,000
Next Earnings Date	2026-08-04
Open	8.5
Optionable	Yes
Position In Range	83.33
Ppne	24,920,000
Pre Close	8.59
Price Date	2026-07-23
Ptbv Ratio	3.25
Relative Volume	0.75x
Revenue	52,038,000x
SBC By Revenue	92.84x
Share Based Comp	48,310,000
Tr6m	-22.48%
Us State	Massachusetts
Volume	1,811,974
Z Score	5.3

Ocular Therapeutix, Inc. (OCUL)

Coverage state: Market snapshot only — no published research

Generate the first OCUL analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · OCUL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All OCUL indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on OCUL

Frequently asked questions